Long-Acting Treatment for CKD Anemia
MIRCERA (mircera.com) scores 74 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, in the 37th percentile of 10836 Healthcare brands.
MIRCERA is a long-acting erythropoiesis-stimulating agent (ESA) indicated for the treatment of anemia associated with chronic kidney disease (CKD). It is intended for use by healthcare professionals managing CKD-related anemia and offers an extended dosing interval compared to other ESA treatments. MIRCERA is classified within the healthcare category and is described in knowledge-graph terms as a mammalian protein found in Homo sapiens.
| Brand Name | MIRCERA |
|---|---|
| Domain | mircera.com |
| Industry | Healthcare |
| Main Competitors | Epogen (74/100), Procrit (61/100), Aranesp (69/100), Retacrit (66/100), Vafseo (70/100) |
Moz Domain Authority 18/100 vs category average 41 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
MIRCERA has a dedicated Wikipedia entity - a top-weighted signal AI models rely on to identify and describe the brand.
The homepage meta description reads "MIRCERA® is a long-acting erythropoiesis-stimulating agent (ESA) used for the treatment of anemia associated with chronic kidney disease (CKD)." (Meta description: 19 words (ideal length). No OG description (falling back to meta)) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on X (Twitter), Instagram; no detected presence on LinkedIn, Facebook, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is MIRCERA?", Claude could identify the brand as of September 2026. Mircera (methoxy polyethylene glycol-epoetin beta) is a long-acting erythropoiesis-stimulating agent made by Roche, used to treat anemia associated with chronic kidney disease. Best known for Being a long-acting ESA that allows less frequent dosing (once monthly) for anemia in chronic kidney disease patients.
When asked "Best brands similar to MIRCERA?", Claude would recommend MIRCERA as of September 2026. It's a well-known branded ESA and a relevant option to mention alongside drugs like Aranesp and Epogen for CKD-related anemia treatment.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
MIRCERA's main competitors in Healthcare: Epogen (74/100), Procrit (61/100), Aranesp (69/100), Retacrit (66/100), Vafseo (70/100).
Sources: Brand Analyzer scan
MIRCERA offers a long-acting erythropoiesis-stimulating agent (ESA) specifically designed for the treatment of anemia associated with chronic kidney disease.
Sources: MIRCERA official site
MIRCERA is a long-acting erythropoiesis-stimulating agent (ESA) used for the treatment of anemia associated with chronic kidney disease (CKD).
Sources: MIRCERA official site
MIRCERA has limited AI-search visibility, scoring 42/100 on Brand Analyzer's AI visibility composite (visibility 57, trust 17, recommendation 45). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: MIRCERA official site
MIRCERA stimulates erythropoiesis (red blood cell production) to treat anemia in patients with chronic kidney disease, offering an extended dosing interval compared to other ESA treatments.
Sources: MIRCERA official site
MIRCERA scores 45/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: MIRCERA official site
MIRCERA can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: MIRCERA official site
MIRCERA is used by US healthcare professionals who treat patients with anemia associated with chronic kidney disease.
Sources: MIRCERA official site
MIRCERA is known for being a long-acting ESA option for managing anemia associated with chronic kidney disease, distinguished by its extended dosing interval relative to other ESAs.
Sources: MIRCERA official site
MIRCERA scores 42/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
MIRCERA has a limited AI-visibility profile at 42/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is visibility (57/100) and its weakest is trust (17/100). It benefits from a recognised Wikipedia company entity, a Wikidata knowledge-graph entry and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: a low Moz Domain Authority of 18/100, thin schema.org structured data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify MIRCERA from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to MIRCERA: Millie Moon (74/100), Milann (74/100), Mirum Pharmaceuticals (74/100), Mannerheimin Lastensuojeluliitto (MLL) (74/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.